Amneal Pharmaceuticals Inc (NASDAQ:AMRX) does about 1.59M shares in volume on a normal day but saw 3849802 shares change hands in Friday trading. The company now has a market cap of 2.09B USD. Its current market price is $6.76, marking an increase of 8.86% compared to the previous close of $6.21. The 52 week high reached by this stock is $6.46 whilst the lowest price level in 52 weeks is $1.74.
Amneal Pharmaceuticals Inc (AMRX) has a 20-day trading average at $5.78 and the current price is 4.64% off the 52-week high compared with 288.51% distance from its 52-week low. The 50-day simple moving average of the closing price is $5.75 and its 200-day simple moving average is $4.84. If we look at the stock’s price movements over the week, volatility stands at 6.77%, which decreases to 5.02% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 72.61 to suggest the stock is overbought.
The consensus objective for the share price is $7.31, suggesting that the stock has a potential upside of 7.52% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 07, 2021 when RBC Capital Mkts resumed the stock to “Sector Perform” and issued a price target of $5. Goldman upgraded the stock to “Buy” from Sell on March 08, 2021 at a price target of $4-$6.50. Guggenheim upgraded its price target at $5.50.
Amneal Pharmaceuticals Inc (AMRX) stock is up 15.16% over the week and 13.42% over the past month. Its price is 11.37% year-to-date and 261.50% over the past year.
To reach the target analysts have set, the stock logically needs to grow 7.52 percent from here.
The company has a return on investment of -6.88% and return on equity of -146.19%. The forward price to earnings ratio is 10.02. The beta has a value of 1.18. Price to book ratio is 104.77 and price to sales ratio is 0.84.
